Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $7 | $5 | $4 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $6 | $8 | $6 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -10.5% | 34.1% | -27.5% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 98.4% | 98.8% | 97.6% | 98.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -50.2% | -29.9% | -38.8% | -0.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -64.4% | -46.5% | -45.9% | -3.5% |
| EPS Diluted | -3.04 | -2.56 | -1.9 | -0.2 |
| % Growth | -18.8% | -34.7% | -850% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$0 | -$0 | $0 |